Skip to main content
Elsevier Sponsored Documents logoLink to Elsevier Sponsored Documents
. 2022 Sep;22(9):e239. doi: 10.1016/S1473-3099(22)00441-8

Correction to Lancet Infect Dis 2022; 22: 438–40

PMCID: PMC9278881  PMID: 35841923

Parker EPK, Desai S, Marti M, et al. Emerging evidence on heterologous COVID-19 vaccine schedules—to mix or not to mix? Lancet Infect Dis 2022; 22: 438–40—The appendix of this Comment has been corrected as of July 13, 2022.

RESOURCES